Clinical Trial Update: Effects of Pasireotide Lar Therapy on Bone Metabolism

View source ↗

Summary

A clinical trial is investigating the effects of pasireotide long-acting release on bone metabolism in individuals with acromegaly caused by a pituitary adenoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Pasireotide LAR (pasireotide)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Acromegaly Due to Pituitary Adenoma, Acromegaly | Status: RECRUITING